The effectiveness of child-resistant packaging for aspirin

Archives of Pediatrics and Adolescent Medicine

Volumn 156, Issue 9, 2002, Pages 929-933

  Rodgers, Gregory B ^a  

^a US Consumer Product Safety Commission   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ARTICLE; BINOMIAL DISTRIBUTION; CHILD RESISTANT CONTAINER; CHILDHOOD MORTALITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG INTOXICATION; DRUG PACKAGING; DRUG SAFETY; HUMAN; INFANT; MULTIVARIATE ANALYSIS OF COVARIANCE; NEWBORN; OUTCOMES RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; SIDE EFFECT; STATISTICAL MODEL;

EID: 0036766122     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.156.9.929     Document Type: Article

References (23)

1. National Center for Health Statistics. Vital Statistics of the United States, Volume 2: Annual Mortality Data. Hyattsville, Md: National Center for Health Statistics; 1958-1993 Public-use files.
2. Food and Drug Administration. Child protection packaging standards for preparations containing aspirin. Fed Regist. 1971;36:17512.
3. Tainter ML, Ferris AJ. Aspirin in Modern Therapy: A Review. New York, NY: Sterling Drug Inc; 1969.
4. Poison Prevention Packaging Act, 15 USC §1471-1476 (1970).
5. Food and Drug Administration. Child protection packaging standards for preparations containing aspirin. Fed Regist. 1972;37:3427-3429.
6. Clark A, Walton WW. Effect of safety packaging on aspirin ingestion by children. Pediatrics. 1979;63:687-693.
7. Viscusi WK. Consumer behavior and the safety effects of product safety regulation. J Law Econ. 1985;28:527-553.
8. World Health Organization. International Classification of Diseases, Seventh Revision (ICD-7). Geneva, Switzerland: World Health Organization; 1957.
9. World Health Organization International Classification of Diseases, Eighth Revision (ICD-8). Geneva, Switzerland: World Health Organization; 1967.
10. World Health Organization. International Classification of Diseases, Ninth Revision (ICD-9). Geneva, Switzerland: World Health Organization; 1977.
11. US Bureau of the Census. Current Population Reports, 1958-1990. Washington, DC: US Government Printing Office; April 1975, July 1982, and February 1993. Series P-25, Nos. 519, 917, and 1095.
12. US International Trade Commission Synthetic Organic Chemicals Annual Reports. Washington, DC: US International Trade Commission; 1958-1991.
13. National Safety Council. Accident Facts, 1999 Edition. Itasca, III: National Safety Council; 1999.
14. McCullagh P, Nelder JA. Generalized Linear Models. 2nd ed. New York, NY: Chapman & Hall; 1989.
15. Agresti A. An Introduction to Categorical Analysis. New York, NY: John Wiley & Sons; 1996.
16. Cameron AC, Trivedi PK. Regression Analysis of Count Data. New York, NY: Cambridge University Press; 1998.
17. Knapp JF. A call to action: the Institute of Medicine report on emergency medical services to children. Pediatrics. 1995;96(suppl 1, pt 2):173-174.
18. Litovitz T, Manoguerra A. Comparison of pediatric poisoning hazards: an analysis of 3.8 million exposure incidents, Pediatrics. 1992;89:999-1006.
19. Centers for Disease Control. Surgeon general's advisory on the use of salicylates and Reye syndrome. MMWR Morb Mortal Wkly Rep. 1982;31:289-290.
20. Proprietary Association. Safety Packaging in the '70's: Proceedings of a Conference Sponsored by the Scientific Development Committee. Washington, DC: Proprietary Association: 1970.
21. Myers RH. Classical and Modern Regression With Applications. 2nd ed. Belmont, Calif: Duxbury Press; 1990.
22. Rodgers GB. The safety effects of child-resistant packaging for oral prescription drugs: two decades of experience JAMA. 1996;275:1661-1665.
23. US Consumer Product Safety Commission. Requirements for the special packaging of household substances: final rule. Fed Regist. 1995;60:37710-37744.